ALDH1A1 and melanoma: Moreover, conventional marker‐based CSCs, such as CD133+, ALDH1+, or SP+ CSCs, isolated from melanoma or breast cancer cells, contain both soft and stiff subsets; and only the soft subpopulation has the ability to form a tumor.